Podiatrist, Foot & Ankle Surgery · New York, NY
NPI
1164425427
Since 2005
Specialty
Podiatrist, Foot & Ankle Surgery
Code 213ES0103X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
347 5th Ave, #1110
New York, NY, 10016
Phone (212) 629-5090
Groups this clinician bills Medicare through
Medicare paid, 2024
$83K
1,234 services
Medicare patients, 2024
259
Average age 74
Drug cost, 2024
$150K
1,126 prescriptions
Company payments, 2025
$26.04
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Steve Menna was code 99213 (office e&m - established), 526 times for 199 patients. In total Steve Menna billed 1,234 services in 34 codes, and Medicare paid $83K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-02-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 526 | 199 | $72.09 | $38K |
| 11721 Nail Procedure | Office | 186 | 115 | $35.03 | $6,515 |
| 11305 Removal or Shaving of Skin Growth | Office | 166 | 94 | $80.67 | $13K |
| 73620 X-ray - Lower Extremity | Office | 93 | 49 | $21.50 | $2,000 |
| 99203 Office E&M - New | Office | 68 | 68 | $85.43 | $5,809 |
| 20600 Joint Injection | Office | 42 | 29 | $41.01 | $1,723 |
| 11730 Nail Procedure | Office | 34 | 29 | $89.20 | $3,033 |
By year: 2022 $92K for 1,156 services; 2023 $110K for 1,346 services; 2024 $83K for 1,234 services.
Medicare prescription drug claims, 2024
In 2024, the drug Steve Menna prescribed most often to Medicare patients was Meloxicam, with 138 prescriptions and refills. In total Steve Menna wrote 1,126 Medicare prescriptions that cost $150K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Meloxicam Generic | 138 | 144 | 95 | $311 |
| Cyanocobalamin Injection Cyanocobalamin (Vitamin B-12) | 113 | 113 | 45 | $5,203 |
| Ketoconazole Generic | 82 | 93 | 43 | $4,263 |
| Terbinafine Hcl Generic | 68 | 68 | 29 | $494 |
| Gabapentin Generic | 57 | 57 | 27 | $962 |
| Clotrimazole Generic | 54 | 54 | 26 | $3,044 |
| Piroxicam Generic | 45 | 45 | 17 | $7,549 |
| Lidocaine Generic | 45 | 52 | 20 | $11K |
| Halobetasol Propionate Generic | 43 | 47 | 21 | $5,818 |
| Diclofenac Epolamine Generic | 42 | 43 | 16 | $29K |
| Diflorasone Diacetate Generic | 39 | 59 | 20 | $33K |
| Ammonium Lactate Generic | 36 | 39 | 14 | $892 |
| Diclofenac Sodium Generic | 35 | 43 | 16 | $12K |
| Naproxen Generic | 34 | 34 | 17 | $1,570 |
| Tavaborole Generic | 33 | 43 | 13 | $9,967 |
Brand drugs: 100 claims; generic drugs: 1,026 claims; opioid claims: 13.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Steve Menna $26.04 ($26.04 in general payments such as food, travel and fees) from 1 company. The largest payer was Abbvie Inc. with $26.04.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 1 | $26.04 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.